Radiation-associated cardiac disease, a heterogeneous and complex disease, manifests
years or even decades following radiation exposure to the chest. It is associated with a …

Abstract The International Lymphoma Radiation Oncology Group (ILROG) guidelines for
using radiation therapy (RT) in hematological malignancies are widely used in many …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide
recommendations for the management of adult patients with HL. The NCCN panel meets at …

Offering comprehensive coverage of the clinical, physical, and technical aspects of radiation
treatment planning, Khan's Treatment Planning in Radiation Oncology, Fifth Edition …

Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL)
and nodular lymphocyte–predominant HL are the 2 main types of HL. The cure rates for HL …

This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology
focuses on considerations for the comprehensive care of AYA patients with cancer …

Involved node radiation therapy for lymphoma was introduced with the aim of using the
smallest effective treatment volume, individualized to the patient's disease distribution, to …

Purpose Mean heart dose (MHD) correlates with late cardiac toxicity among survivors of
lymphoma receiving involved-field radiation therapy (IFRT). We investigated MHD and …

In the multidisciplinary management of early-stage extranodal natural killer/T-cell lymphoma,
nasal type (ENKTCL), with curative intent, radiation therapy is the most efficacious modality …